BY CHRISTOPHER DUE KARLSSON
-
Roche’s neuromuscular disease tablet receives EU approval
The European Commission has approved a tablet version of the already approved drug Evrysdi from Swiss company Roche.
-
Leo Pharma boss on new HR director: “Hard to overestimate the importance of the task”
Helle Hedegaard Juhl was picked as the brand-new human resources supervisor since she brings greater than twenty years of experience from duties in human resources in various other…
-
Coloplast to present new five-year strategy in September
Last month, the Danish medtech firm terminated its chief executive officer when results underperformed assumptions. The shooting came simply days after an assistance downgrade.
-
Leo Pharma starts trial with skin disease cream as part of new strategy
The Danish dermatology business sees development possibility and anticipates to release much more tests with the medicine prospect in the future, specifies the business’s chi…
-
Headhunter sees Ambu director among four candidates for top Coloplast job
Previously this month, Coloplast terminated its chief executive officer, and Henrik Brabrand from employment firm Albright Allies highlights clear prospects.
-
A smart solution from LINAK for heavy lifts in your automation projects
POSTED 05/27/2025 Designed to manufacture your job more straightforward Integrating heavy lifts into your automation initiatives need to no longer be advanced. With the LINAK® LC3 IC lifting column, you bag a ready-to-spend lifting solution from one single dealer. This reduces complexity, eliminates time-ingesting calculations and testing, and simplifies each dimensioning and commissioning of sub-parts.
-
Regeneron acquires US biotech firm
Regeneron Pharmaceuticals is readied to pay USD 256m for biotech firm 23andMe.
-
Novo Nordisk Foundation increases its support to WHO
The strengthened collaboration will certainly concentrate on the expanding worldwide difficulty of non-communicable conditions, according to the Novo Nordisk Structure.
-
China will provide extra support to WHO
According to China’s vice premier, over the following 5 years, the nation will certainly offer an added USD 500m to the that.
-
Regeneron acquires US biotech firm
Regeneron Pharmaceuticals is set to pay USD 256m for biotech company 23andMe.
